SMYD2 and neoplasm: Comparable numbers of Ki67-positive cells were detected in WT and Smyd2 deficient MC-38 tumor implants (Fig. 2E) and also from the WT and SMYD2 deficient HT-29 tumor implants (Fig. 2F), suggesting that SMYD2 is dispensable for regulating cell proliferation in vivo.